Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Alano Martins Pedrosa"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 4, Pp 468-475 (2021)
Introduction: Although the efficacy of hydroxyurea (HU) in inhibiting erythrocyte sickling has been well demonstrated, the action of this drug on human neutrophils and the mechanism by which it improves the manifestations of the disease have not been
Externí odkaz:
https://doaj.org/article/c923064b0797471aa27a538ff3a97fb9
Autor:
Alano Martins Pedrosa, Maritza Cavalcante Barbosa, Thayna Nogueira dos Santos, Luzia Kalyne Almeida Moreira Leal, Amanda de Araújo Lopes, Darcielle Bruna Dias Elias, Greyce Luri Sasahara, Bruno Coêlho Cavalcanti, Romélia Pinheiro Gonçalves
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 50, Iss 2, Pp 401-410 (2014)
Hydroxyurea (HU) is the most important advance in the treatment of sickle cell anaemia (SCA) for preventing complications and improving quality of life for patients. However, some aspects of treatment with HU remain unclear, including their effect on
Externí odkaz:
https://doaj.org/article/93067a93b42b4d74bbf1ae6e7f75b148
Autor:
Darcielle Bruna Dias Elias, Lilianne Brito da Silva Rocha, Maritza Barbosa Cavalcante, Alano Martins Pedrosa, Izabel Cristina Bandeira Justino, Romélia Pinheiro Gonçalves
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 34, Iss 4, Pp 265-269 (2012)
BACKGROUND: Sickle cell disease is a hemoglobinopathy characterized by hemolytic anemia, increased susceptibility to infections and recurrent vaso-occlusive crises that reduces the quality of life of sufferers. OBJECTIVE: To evaluate the correlation
Externí odkaz:
https://doaj.org/article/de4509db93124522bd8682ffcf3ddb15
Autor:
Alano Martins Pedrosa
Publikováno v:
Biblioteca Digital de Teses e Dissertações da UFCUniversidade Federal do CearáUFC.
CoordenaÃÃo de AperfeiÃoamento de Pessoal de NÃvel Superior
Falciform Anemia (FA) is a hereditary hemoglobinopathy resulting from a β-globin gene mutation (α2β26 GLU→ VAL) that originates a hemoglobin variant called S (HbS). Its polymer
Falciform Anemia (FA) is a hereditary hemoglobinopathy resulting from a β-globin gene mutation (α2β26 GLU→ VAL) that originates a hemoglobin variant called S (HbS). Its polymer
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 4, Pp 468-475 (2021)
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy, Volume: 43, Issue: 4, Pages: 468-475, Published: 29 NOV 2021
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy, Volume: 43, Issue: 4, Pages: 468-475, Published: 29 NOV 2021
Introduction: Although the efficacy of hydroxyurea (HU) in inhibiting erythrocyte sickling has been well demonstrated, the action of this drug on human neutrophils and the mechanism by which it improves the manifestations of the disease have not been
Publikováno v:
British Journal of Haematology. 190
Hypoxia and hemoglobin S polymerization are two triggers responsible for initiating erythrocyte sickling and the consequent clinical sickle cell anemia (SCA) events. The objective of this study was to investigate the expression of hypoxia-responsive
Autor:
Romélia Pinheiro Gonçalves Lemes, Thayna Nogueira dos Santos, Luzia Kalyne Almeida Moreira Leal, Greyce Luri Sasahara, Talyta Ellen de Jesus dos Santos, Amanda de Araújo Lopes, Darcielle Bruna Dias Elias, Maritza Cavalcante Barbosa, Alano Martins Pedrosa
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 118:271-278
The aim of the study was to investigate the possible anti-inflammatory and antioxidant effects of BAY 73-6691 on neutrophils from SCA patients. This study included 35 patients with a molecular diagnosis of SCA, whose neutrophils were isolated and tre
Autor:
Renata Mirian Nunes Eleutério, Romélia Pinheiro Gonçalves Lemes, Alano Martins Pedrosa, Francisco O. F. Nascimento
Publikováno v:
II Encontro do Programa de Pós-Graduação em Ciências Farmacêuticas da Universidade Federal do Ceará e I Simpósio Norte-Nordeste de Ciências Farmacêuticas.
Autor:
Darcielle Bruna Dias Elias, Maritza Cavalcante Barbosa, Amanda de Araújo Lopes, Greyce Luri Sasahara, Bruno C. Cavalcanti, Alano Martins Pedrosa, Luzia Kalyne Almeida Moreira Leal, Romélia Pinheiro Gonçalves, Thayna Nogueira dos Santos
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Volume: 50, Issue: 2, Pages: 401-410, Published: APR 2014
Brazilian Journal of Pharmaceutical Sciences; Vol. 50 No. 2 (2014); 401-410
Brazilian Journal of Pharmaceutical Sciences; Vol. 50 Núm. 2 (2014); 401-410
Brazilian Journal of Pharmaceutical Sciences; v. 50 n. 2 (2014); 401-410
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Vol 50, Iss 2, Pp 401-410 (2014)
Brazilian Journal of Pharmaceutical Sciences; Vol. 50 No. 2 (2014); 401-410
Brazilian Journal of Pharmaceutical Sciences; Vol. 50 Núm. 2 (2014); 401-410
Brazilian Journal of Pharmaceutical Sciences; v. 50 n. 2 (2014); 401-410
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Vol 50, Iss 2, Pp 401-410 (2014)
Hydroxyurea (HU) is the most important advance in the treatment of sickle cell anaemia (SCA) for preventing complications and improving quality of life for patients. However, some aspects of treatment with HU remain unclear, including their effect on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::274bb1c4bf9dfb40da222e77ff19e41b
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502014000200401&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502014000200401&lng=en&tlng=en
Autor:
Romélia Pinheiro Gonçalves, Darcielle Bruna Dias Elias, Maritza Barbosa Cavalcante, Izabel Cristina Bandeira Justino, Lilianne Brito da Silva Rocha, Alano Martins Pedrosa
Publikováno v:
Repositório Institucional da Universidade Federal do Ceará (UFC)
Universidade Federal do Ceará (UFC)
instacron:UFC
Revista Brasileira de Hematologia e Hemoterapia, Vol 34, Iss 4, Pp 265-269 (2012)
Revista Brasileira de Hematologia e Hemoterapia
Revista Brasileira de Hematologia e Hemoterapia v.34 n.4 2012
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Revista Brasileira de Hematologia e Hemoterapia, Volume: 34, Issue: 4, Pages: 265-269, Published: 2012
Universidade Federal do Ceará (UFC)
instacron:UFC
Revista Brasileira de Hematologia e Hemoterapia, Vol 34, Iss 4, Pp 265-269 (2012)
Revista Brasileira de Hematologia e Hemoterapia
Revista Brasileira de Hematologia e Hemoterapia v.34 n.4 2012
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Revista Brasileira de Hematologia e Hemoterapia, Volume: 34, Issue: 4, Pages: 265-269, Published: 2012
BACKGROUND: Sickle cell disease is a hemoglobinopathy characterized by hemolytic anemia, increased susceptibility to infections and recurrent vaso-occlusive crises that reduces the quality of life of sufferers. OBJECTIVE: To evaluate the correlation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38bf3f50c1daedb0dc157ea0f111978e
http://www.repositorio.ufc.br/handle/riufc/5786
http://www.repositorio.ufc.br/handle/riufc/5786